首页> 外国专利> Method of drug loading in cell-derived membrane vesicles by engineering parent cells with membrane fusogenic liposomes and drug delivery method using thereof

Method of drug loading in cell-derived membrane vesicles by engineering parent cells with membrane fusogenic liposomes and drug delivery method using thereof

机译:通过用膜融合脂质体改造亲代细胞而在细胞衍生的膜囊泡中载药的方法及其使用的药物递送方法

摘要

The present invention relates to a cell membrane vesicle encapsulated with a drug prepared using membrane fusogenic liposome (MFL), a method for producing the cell membrane vesicle and a drug delivery method using the cell membrane vesicle, , The cell membrane vesicle of the present invention can simultaneously encapsulate a hydrophilic drug and a hydrophobic drug, and it is a cell membrane vesicle isolated from a cell, so as to enable more efficient and selective drug delivery to peripheral cells, Because of the safety of the material and the step of enclosing the drug directly in the cell membrane vesicle, there is no need for the cell membrane vesicle to be useful for the prevention and treatment of various cancer and degenerative diseases known to play an important role in cell membrane vesicles.
机译:本发明涉及用膜融合脂质体(MFL)制得的药物包封的细胞膜囊泡,该细胞膜囊泡的制造方法及该细胞膜囊泡的给药方法,本发明的细胞膜囊泡可以同时包封亲水性药物和疏水性药物,并且它是从细胞中分离出来的细胞膜囊泡,从而能够更有效和选择性地将药物递送至周围细胞,因为这种材料的安全性和封闭药物的步骤药物直接在细胞膜囊泡中使用,不需要细胞膜囊泡用于预防和治疗已知在细胞膜囊泡中起重要作用的各种癌症和变性疾病。

著录项

  • 公开/公告号KR101586036B1

    专利类型

  • 公开/公告日2016-01-27

    原文格式PDF

  • 申请/专利权人 한국과학기술원;

    申请/专利号KR20140032446

  • 发明设计人 박지호;이준성;김지영;

    申请日2014-03-20

  • 分类号A61K9/127;A61K47/30;A61K47/48;

  • 国家 KR

  • 入库时间 2022-08-21 14:13:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号